Clinical Trial Update: Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 4 cycles versus 6 cycles of TC (docetaxel + cyclophosphamide) as adjuvant chemotherapy for early breast cancer with 1-3 positive lymph n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Docetaxel + Cyclophosphamide (TC)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN